EPIC Program Annual Data Tables 2008-2009 Appendix: Table IX
| Rank by Payment | Drug and Strength | Drug Type** | Number of Claims | EPIC Payments | Rank by Number of Claims |
|---|---|---|---|---|---|
| Top 20 Totals | 1,220,462 | $114,088,134 | |||
| Percent of Top 20 Drugs to Total EPIC Payments | 12.05% | 30.03% | |||
| 1 | PLAVIX (75 MG) | SS | 184,753 | $17,234,750 | 1 |
| 2 | NEXIUM (40 MG) | SS | 109,156 | $12,726,312 | 6 |
| 3 | PREVACID (30 MG) | SS | 58,371 | $7,864,413 | 26 |
| 4 | LIPITOR (20 MG) | SS | 85,484 | $7,326,087 | 14 |
| 5 | LIPITOR (10 MG) | SS | 103,607 | $6,245,068 | 8 |
| 6 | ARICEPT (10 MG) | SS | 59,906 | $6,044,200 | 24 |
| 7 | SPIRIVA (18MCG) | SS | 79,470 | $5,929,431 | 15 |
| 8 | FLOMAX (0.4 MG) | SS | 73,896 | $4,888,175 | 19 |
| 9 | ADVAIR DISKUS (250-50MCG) | SS | 58,228 | $4,716,712 | 27 |
| 10 | PANTOPRAZOLE SODIUM (40 MG) | Gen | 68,257 | $4,674,584 | 22 |
| 11 | LIPITOR (40 MG) | SS | 52,129 | $4,551,605 | 31 |
| 12 | ACIPHEX (20 MG) | SS | 25,282 | $4,325,467 | 92 |
| 13 | ZETIA (10 MG) | SS | 50,316 | $3,848,999 | 36 |
| 14 | ARIMIDEX (1 MG) | SS | 16,452 | $3,590,424 | 156 |
| 15 | JANUVIA (100 MG) | SS | 29,500 | $3,524,852 | 74 |
| 16 | NAMENDA (10 MG) | SS | 44,863 | $3,481,703 | 44 |
| 17 | PROCRIT (40000/ML) | BNMS | 2,977 | $3,384,295 | 612 |
| 18 | CELEBREX (200 MG) | SS | 38,155 | $3,299,165 | 52 |
| 19 | ACTONEL (35 MG) | SS | 50,551 | $3,294,285 | 34 |
| 20 | LIDODERM (5%(700MG)) | SS | 29,109 | $3,137,607 | 75 |
* Table IX lists the top 20 drugs ranked by EPIC Payments and number of adjudicated claims for the program year (October 1, 2008-September 30, 2009) as well as the percentage of the totals they represent for the year.
** Drug Type values are BNMS='Brand Name Multi-Source', Gen='Generic' and SS='Sole Source.'
